Adjusted EBITDA is a supplemental performance measure that our management uses to assess our operating performance and the operating leverage in our business.

filing / Aug 4, 2026 / receipt

For the three months ended June 30, 2026 and 2025, the Company incurred $3 million and $6 million, respectively, of restructuring expenses related to workforce reductions, associated consulting fees, and lease termination cost.

filing / Aug 4, 2026 / receipt

For the six months ended June 30, 2026 and 2025, the Company incurred $3 million and $9 million, respectively, of restructuring expenses related to workforce reductions, associated consulting fees, and lease termination costs.

filing / Aug 4, 2026 / receipt

During the six months ended June 30, 2025, the Company recognized $ 6 million of restructuring expenses related to post-employment benefits for approximately 125 employees, as well as other cost reduction efforts.

filing / Aug 4, 2026 / receipt

We continually evaluate opportunities to expand our footprint. At the start of 2025, our products were available in 50 markets across select U.S.

filing / Aug 4, 2026 / receipt

Adjusted EBITDA is a supplemental performance measure that our management uses to assess our operating performance and the operating leverage in our business.

filing / May 7, 2026 / receipt

For the three months ended March 31, 2025, the Company incurred $ 3 million of restructuring expenses related to workforce reductions and associated consulting fees, with no such expenses incurred during the three months ended March 31, 2026.

filing / May 7, 2026 / receipt

During the three months ended March 31, 2025, the Company recognized $ 3 million of restructuring expenses related to post-employment benefits for approximately 65 employees, as well as other cost reduction efforts.

filing / May 7, 2026 / receipt

We continually evaluate opportunities to expand our footprint. At the start of 2025, our products were available in 50 markets across select U.S.

filing / May 7, 2026 / receipt